Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹347 Cr₹317 Cr₹261 Cr₹237 Cr₹60 Cr

What is the latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES is ₹347 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹347 Cr
Mar2025₹317 Cr
Mar2024₹261 Cr
Mar2023₹237 Cr
Mar2022₹60 Cr

How is Cash Flow from Operating Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹347 Cr
9.22
Mar2025 ₹317 Cr
21.53
Mar2024 ₹261 Cr
10.10
Mar2023 ₹237 Cr
292.81
Mar2022 ₹60 Cr -

Compare Cash Flow from Operating Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹25,554.8 Cr 3.9% 5.6% 39.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -2.6% 2.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹221,666.0 Cr 6.5% 23.3% 25.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,108.0 Cr 2.6% 3% 33.5% Stock Analytics
CIPLA ₹117,139.0 Cr -1.1% -0.2% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,990.9 Cr 2.6% -13.3% -10.7% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

3.9%

5.6%

39.3%

SENSEX

1.2%

0.4%

-2.9%


You may also like the below Video Courses